Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors

被引:32
作者
Kolli, A
Chu, GH
Rhodes, ME
Inoue, K
Selcer, KW
Li, PK [1 ]
机构
[1] Duquesne Univ, Mylan Sch Pharm, Dept Med Chem & Pharmaceut, Pittsburgh, PA 15282 USA
[2] Duquesne Univ, Bayer Sch Nat & Environm Sci, Dept Biol, Pittsburgh, PA 15282 USA
[3] Kyowa Hakko Kogyo Co Ltd, Pharmaceut Res & Dev Ctr, Tokyo, Japan
关键词
D O I
10.1016/S0960-0760(98)00159-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogen levels in breast tumors of postmenopausal women are as much as 10 times higher than estrogen levels in plasma, presumably due to in situ formation of estrogen. The major source of estrogen in breast cancer cells may be conversion of estrone sulfate to estrone by the enzyme estrone sulfatase. Thus, inhibitors of estrone sulfatase are potential agents for treatment of estrogen-dependent breast cancer. Several steroidal compounds have been developed that are potent estrone sulfatase inhibitors, most notably estrone-3-O-sulfamate. However, these compounds and their metabolites may have undesired effects, including estrogenicity. To avoid the problems associated with a potentially active steroid nucleus, we designed and synthesized a series of nonsteroidal estrone sulfatase inhibitors, the (p-O-surfamoyl)-N-arkanoyl phenylalkyl amines. The compounds synthesized vary in the length of their arkanoyl chain and in the number of carbons separating the phenyl ring and the carbonyl carbon. The ability of these compounds to inhibit estrone sulfatase activity was tested using human placental microsomes and intact cultured human breast cancer cells. Estrogenicity was also evaluated, using growth of estrogen-dependent human breast cancer cells. All of the test compounds inhibited estrone sulfatase activity of human placental microsomes to some extent, with the most effective compound having an IC50 value of 72 nM. In general, compounds with longer alkanoyl chains (12-14 carbons) were more effective than those with shorter chains. The test compounds also inhibited estrone sulfatase activity in intact cultures of MDA-MB-231 human breast cancer cells. Again, the longer chain compounds were more effective. In both the placental and breast cancer cell sulfatase assays, the optimal distance between the phenyl ring and the carbonyl carbon was 1-2 carbons. The MCF-7 cell proliferation assay revealed that estrone and estrone-3-O-sulfamate were both estrogenic, but the (p-O-sulfamoyl)-N-alkanoyl phenylalkyl amines were not. Our data indicate the utility of (p-O-sulfamoyl)-N-alkanoyl phenyl alkyl amines for inhibition of estrone sulfatase activity. Furthermore, our data support the concept that nonsteroidal estrone sulfatase inhibitors map be useful as therapeutic agents for estrogen-dependent breast cancers. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 24 条
[1]   Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors [J].
Chu, GH ;
Milano, S ;
Kluth, L ;
Rhodes, M ;
Boni, R ;
Johnson, DA ;
Li, PK .
STEROIDS, 1997, 62 (07) :530-535
[2]  
DUNCAN L, 1993, CANCER RES, V53, P298
[3]   ENDOGENOUS OESTRADIOL-17-BETA CONCENTRATION IN BREAST-TUMORS DETERMINED BY MASS FRAGMENTOGRAPHY AND BY RADIOIMMUNOASSAY - RELATIONSHIP TO RECEPTOR CONTENT [J].
EDERY, M ;
GOUSSARD, J ;
DEHENNIN, L ;
SCHOLLER, R ;
REIFFSTECK, J ;
DROSDOWSKY, MA .
EUROPEAN JOURNAL OF CANCER, 1981, 17 (01) :115-120
[4]  
ELGER W, 1995, J STEROID BIOCHEM, V55, P396
[5]   ESTRONE SULFAMATES - POTENT INHIBITORS OF ESTRONE SULFATASE WITH THERAPEUTIC POTENTIAL [J].
HOWARTH, NM ;
PUROHIT, A ;
REED, MJ ;
POTTER, BVL .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (02) :219-221
[6]   PHOSPHONATES AND THIOPHOSPHONATES AS SULFATE SURROGATES - SYNTHESIS OF ESTRONE 3-METHYLTHIOPHOSPHONATE, A POTENT INHIBITOR OF ESTRONE SULFATASE [J].
HOWARTH, NM ;
COOPER, G ;
PUROHIT, A ;
DUNCAN, L ;
REED, MJ ;
POTTER, BVL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (02) :313-318
[7]  
James V. H. T., 1980, PROG CANCER RES THER, V14, P471
[8]   Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors [J].
Li, PK ;
Milano, S ;
Kluth, L ;
Rhodes, ME .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 59 (01) :41-48
[9]   Development of potent non-estrogenic estrone sulfatase inhibitors [J].
Li, PK ;
Chu, GH ;
Guo, JP ;
Peters, A ;
Selcer, KW .
STEROIDS, 1998, 63 (7-8) :425-432
[10]   DETERMINATION OF HORMONAL STEROID CONCENTRATIONS IN BIOLOGICAL EXTRACTS BY HIGH-RESOLUTION MASS FRAGMENTOGRAPHY [J].
MILLINGTON, DS .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1975, 6 (3-4) :239-245